scaricalo in formato PDF - labogen srl
scaricalo in formato PDF - labogen srl
scaricalo in formato PDF - labogen srl
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
INHIBITORS 8<br />
Pattern Recognition Receptor (PRR) Signal<strong>in</strong>g Inhibitors<br />
BX795 - TBK/IKKε Inhibitor<br />
BX795, an am<strong>in</strong>opyrimid<strong>in</strong>e compound, was developed as an <strong>in</strong>hibitor of 3-phospho<strong>in</strong>ositide-dependent k<strong>in</strong>ase 1 (PDK1) 1 . It was recently shown to be a<br />
potent <strong>in</strong>hibitor of the IKK-related k<strong>in</strong>ases, TANK-b<strong>in</strong>d<strong>in</strong>g k<strong>in</strong>ase 1 (TBK1) and IKKε, and hence of IRF3 activation and IFN-β production 2 . BX795 <strong>in</strong>hibits the<br />
catalytic activity of TBK1/IKKε by block<strong>in</strong>g their phosphorylation.<br />
Chloroqu<strong>in</strong>e - Inhibitor of Endosomal Acidification<br />
Chloroqu<strong>in</strong>e is a lysosomotropic agent that prevents endosomal acidification 3 . It accumulates <strong>in</strong>side the acidic parts of the cell, <strong>in</strong>clud<strong>in</strong>g endosomes and<br />
lysosomes. This accumulation leads to <strong>in</strong>hibition of lysosomal enzymes that require an acidic pH, and prevents fusion of endosomes and lysosomes. Chloroqu<strong>in</strong>e<br />
is commonly used to study the role of endosomal acidification <strong>in</strong> cellular processes, such as the signal<strong>in</strong>g of <strong>in</strong>tracellular TLRs 4, 5 .<br />
CLI-095 - TLR4 Signal<strong>in</strong>g Inhibitor<br />
CLI095, also known as TAK-242, is a novel cyclohexene derivative that specifically suppresses TLR4 signal<strong>in</strong>g, <strong>in</strong>hibit<strong>in</strong>g the production of NO and pro<strong>in</strong>flammatory<br />
cytok<strong>in</strong>es 6 . It acts by block<strong>in</strong>g the signal<strong>in</strong>g mediated by the <strong>in</strong>tracellular doma<strong>in</strong> of TLR4, but not the extracellular doma<strong>in</strong>. It potently suppresses<br />
both ligand-dependent and -<strong>in</strong>dependent signal<strong>in</strong>g of TLR4 7 .<br />
Cyclospor<strong>in</strong> A - Calc<strong>in</strong>eur<strong>in</strong> <strong>in</strong>hibitor NEW<br />
Cyclopspor<strong>in</strong> A is a calc<strong>in</strong>eur<strong>in</strong> <strong>in</strong>hibitor that exerts its immunosuppressive effects through the down-regulation of NFAT (nuclear factor of activated T cells)<br />
transcription factor, thus prevent<strong>in</strong>g the transcription of T cell effector cytok<strong>in</strong>es 8 . Moreover, NFAT has been implicated <strong>in</strong> the downstream signal<strong>in</strong>g of<br />
Dect<strong>in</strong>-1 which is important <strong>in</strong> the <strong>in</strong>nate immune response aga<strong>in</strong>st fungal <strong>in</strong>fection 9 . Conversely, it has been demonstrated that <strong>in</strong>hibition of calc<strong>in</strong>eur<strong>in</strong> <strong>in</strong><br />
macrophages enhances NF-κB activation 10 and can trigger TLR signal<strong>in</strong>g by activat<strong>in</strong>g both the MyD88-dependent and the MyD88-<strong>in</strong>dependent pathways 11 .<br />
Gefit<strong>in</strong>ib - RIP2 Tyros<strong>in</strong>e K<strong>in</strong>ase <strong>in</strong>hibitor NEW<br />
Gefit<strong>in</strong>ib (also known as Iressa) is a selective <strong>in</strong>hibitor of epidermal growth factor, a growth factor that plays a pivotal role <strong>in</strong> the control of cell growth, apoptosis, and<br />
angiogenesis. Recent studies demonstrated that Gefit<strong>in</strong>ib can <strong>in</strong>hibit NOD2-<strong>in</strong>duced cytok<strong>in</strong>e release and NF-kB activation by <strong>in</strong>hibit<strong>in</strong>g RIP2 (receptor-<strong>in</strong>teract<strong>in</strong>g<br />
prote<strong>in</strong> 2) tyros<strong>in</strong>e phosphylation which is critical for activation of NOD2 downsream signal<strong>in</strong>g pathways 12 . Gefit<strong>in</strong>ib is used <strong>in</strong> the treatment of advanced nonsmall cell<br />
lung cancer 13 .<br />
OxPAPC - TLR2 and TLR4 Inhibitor<br />
OxPAPC (1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylchol<strong>in</strong>e), is an oxidized phospholipid that has been shown to <strong>in</strong>hibit the signal<strong>in</strong>g <strong>in</strong>duced by<br />
bacterial lipopeptide and lipopolysaccharide (LPS). It acts by compet<strong>in</strong>g with CD14, LBP and MD2, the accessory prote<strong>in</strong>s that <strong>in</strong>teract with bacterial lipids,<br />
thus block<strong>in</strong>g the signal<strong>in</strong>g of TLR2 and TLR4 14, 15 .<br />
Pep<strong>in</strong>h-MYD - MyD88 <strong>in</strong>hibitory peptide<br />
Pep<strong>in</strong>h-MYD is a 26 aa peptide that blocks MyD88 signal<strong>in</strong>g by <strong>in</strong>hibit<strong>in</strong>g its homodimerization through b<strong>in</strong>d<strong>in</strong>g. Pep<strong>in</strong>h-MYD conta<strong>in</strong>s a sequence from the<br />
MyD88 TIR homodimerization doma<strong>in</strong> (RDVLPGT) 16 preceeded by a prote<strong>in</strong> transduction sequence (RQIKIWFQNRMKWKK) derived from antennapedia<br />
which enables the peptide to translocate through the cell membrane 17 . Pep<strong>in</strong>h-MYD is provided with a control peptide.<br />
Pep<strong>in</strong>h-TRIF - TRIF <strong>in</strong>hibitory peptide<br />
Pep<strong>in</strong>h-TRIF is a 30 aa peptide that blocks TRIF signal<strong>in</strong>g by <strong>in</strong>terfer<strong>in</strong>g with TLR-TRIF <strong>in</strong>teraction. Pep<strong>in</strong>h-TRIF conta<strong>in</strong>s the 14 aa that correspond to the<br />
sequence of the BB loop of TRIF (FCEEFQVPGRGELH) 18 l<strong>in</strong>ked to the cell-penetrat<strong>in</strong>g segment of the antennapedia homoedoma<strong>in</strong><br />
(RQIKIWFQNRMKWKK) 17 . Pep<strong>in</strong>h-TRIF is provided with a control peptide.<br />
Polymyx<strong>in</strong> B - Inhibitor of LPS-<strong>in</strong>duced TLR4 activation<br />
Polymyx<strong>in</strong> B (PMB) is a cyclic cationic polypeptide antibiotic produced by the soil bacterium Paenibacillus polymixa. PMB blocks the biological effects of Gram<br />
negative LPS (endotox<strong>in</strong>) through b<strong>in</strong>d<strong>in</strong>g to lipid A, the toxic component of LPS, which is negatively charged 19, 20 . The neutraliz<strong>in</strong>g effect of PMB on LPS is<br />
dose-related and specific for LPS 21 . PMB is widely used to elim<strong>in</strong>ate the effects of endotox<strong>in</strong> contam<strong>in</strong>ation, both <strong>in</strong> vitro and <strong>in</strong> vivo.<br />
Rapamyc<strong>in</strong> - mTOR Inhibitor<br />
Rapamyc<strong>in</strong> is an <strong>in</strong>hibitor of the Ser/Thr prote<strong>in</strong> k<strong>in</strong>ase named "mammalian target of rapamyc<strong>in</strong>" (mTOR) that regulates cell growth and metabolism <strong>in</strong><br />
response to environmental cues. mTOR is a downstream target of PI3K, an important actor <strong>in</strong> TLR signal<strong>in</strong>g 22 . Rapamyc<strong>in</strong> was shown to block TLR2- and<br />
TLR4-mediated expression of TNF-a and IL-6 <strong>in</strong> neutrophils stimulated with Pam3CSK4 or LPS 23 .<br />
Z-VAD-FMK - Caspase Inhibitor<br />
Z-VAD-FMK is a cell-permeable pan-caspase <strong>in</strong>hibitor that irreversibly b<strong>in</strong>ds to the catalytic site of caspase proteases 24 . The peptide is O-methylated <strong>in</strong> the<br />
P1 position on aspartic acid, provid<strong>in</strong>g enhanced stability and <strong>in</strong>creased cell permeability. Z-VAD-FMK is used <strong>in</strong> apoptosis studies and also <strong>in</strong> <strong>in</strong>flammasome<br />
studies. It is a potent <strong>in</strong>hibitor of caspase-1 activation <strong>in</strong> NLRP3-<strong>in</strong>duced cells 25 .<br />
1. Feldman RI. et al., 2005. Novel Small Molecule Inhibitors of 3-Phospho<strong>in</strong>ositide-dependent K<strong>in</strong>ase-1. J. Biol. Chem., 280: 19867 - 19874. 2. Clark K. et al., 2009. Use of the Pharmacological<br />
Inhibitor BX795 to Study the Regulation and Physiological Roles of TBK1 and I{kappa}B K<strong>in</strong>ase {epsilon}: a dist<strong>in</strong>ct upstream k<strong>in</strong>ase mediates Ser-172 phosphorylation and activation. J. Biol.<br />
Chem. 284: 14136 - 14146. 3. Ste<strong>in</strong>man RM. et al., 1983. Endocytosis and the recycl<strong>in</strong>g of plasma membrane. J. Cell. Biol. 96:1-27. 4. Rutz, M. et al., 2004. Toll-like receptor 9 b<strong>in</strong>ds s<strong>in</strong>glestranded<br />
CpG-DNA <strong>in</strong> a sequence- and pH-dependent manner. Eur. J. Immunol. 34:2541-2550. 5. Hart OM. et al., 2005.TLR7/8-Mediated Activation of Human NK Cells Results <strong>in</strong> Accessory<br />
Cell-Dependent IFN-{gamma} Production. J. Immunol., 175: 1636 - 1642. 6. Li M. et al., 2006. A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-<br />
1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytok<strong>in</strong>e Production through Suppression of Intracellular Signal<strong>in</strong>g. Mol. Pharmacol., 69: 1288 - 1295.<br />
7. Kawamoto T. et al., 2008. TAK-242 selectively suppresses Toll-like receptor 4-signal<strong>in</strong>g mediated by the <strong>in</strong>tracellular doma<strong>in</strong>. Eur J Pharmacol. 584(1):40-8. 8. Chow CW. et al., 1999.<br />
Requirement for transcription factor NFAT <strong>in</strong> <strong>in</strong>terleuk<strong>in</strong>-2 expression. Mol Cell Biol. 19(3): 2300-07. 9. Goodridge et al. 2007. Dect<strong>in</strong>-1stimulation by Candida albicans yeast or zymosan<br />
154 www.<strong>in</strong>vivogen.com/<strong>in</strong>hibitors